Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Mast cells might contribute to hair loss by causing skin thickening.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Rituximab may cause skin issues, but baricitinib can help improve them.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

A patient's grey hair regained color during treatment with adalimumab.

Composite biomaterials can precisely control immune responses for better disease treatment.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Using old drugs for new uses can help treat rare immune deficiencies.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Regulatory T cells are essential for normal and improved wound healing in mice.